Gly-PEG3-BA-生命科学试剂-MCE.pdfVIP

  • 0
  • 0
  • 约6.03千字
  • 约 2页
  • 2026-03-06 发布于上海
  • 举报

Hotline:400-820-3792

Inhibitors•ScreeningLibraries•Proteins

www.MedChemE

Gly-PEG3-BA

Cat.No.:HY-180966

CASNo.:3057939-66-6

分⼦式:C₃₄H₄₈ClN₈O₇P

分⼦量:747.22

作⽤靶点:PROTACs;EGFR

作⽤通路:PROTAC;JAK/STATSignaling;ProteinTyrosineKinase/RTK

储存⽅式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

⽣物活性Gly-PEG3-BA是⼀种靶向EML4-ALK的PROTAC降解剂。Gly-PEG3-BA在H3122细胞(EML4-ALK阳性细胞)

中可有效降解EML4-ALK蛋⽩,其DC50为0.50μM;Gly-PEG3-BA在H1975细胞(EGFRL858R/T790M双突

变细胞)中能显著降低EGFR突变体(L858R/T790M)的蛋⽩⽔平,对应的DC50值为20.15μM。此外,Gly-

PEG3-BA对H3122细胞与H1975细胞均具有强效抗增殖活性,其IC50分别为0.84μM与20.74μM。Gly-

PEG3-BA可⽤于⾮⼩细胞肺癌的相关研究[1]。

IC50TargetEML4-ALK

体外研究Gly-PEG3-BA(0-20μM,72h)exhibitshighlytarget-selectiveactivityagainstEGFRinH1975cells(harboring

theEGFRL858R/T790Mdoublemutation)andinducesdose-dependenttargeteddegradationoftheEML4-

ALKfusionproteininH3122(EML-ALK)cells[1].

Gly-PEG3-BA(0-20μM,48or72h)tunedownEML4-ALKandEGFRmutantefficientlyandconferpotent

antiproliferationactivityinH3122(EML-ALK)andH1975(EGER-L858R/T790M)cellswithIC50valuesof

0.84and20.74μM[1].

文档评论(0)

1亿VIP精品文档

相关文档